We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
(+18%)
Cap. Flow
+$1.47B
Cap. Flow
% of AUM
10.47%
Top 10 Holdings %
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$177M |
| 2 |
Lowe's Companies
LOW
|
+$108M |
| 3 |
STJ
St Jude Medical
STJ
|
+$95.4M |
| 4 |
Newell Brands
NWL
|
+$88.6M |
| 5 |
Constellation Brands
STZ
|
+$87.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$136M |
| 2 |
UnitedHealth
UNH
|
+$99.3M |
| 3 |
PayPal
PYPL
|
+$85.4M |
| 4 |
Starbucks
SBUX
|
+$78.1M |
| 5 |
Cigna
CI
|
+$64.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.63% |
| 2 | Consumer Discretionary | 12.48% |
| 3 | Communication Services | 12.09% |
| 4 | Technology | 9.72% |
| 5 | Industrials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PINC
626
DELISTED
Premier
PINC
| $1.73M | 0.01% |
53,608
+27,517
| +105% | +$892K |
|
|
MEET
627
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $1.72M | 0.01% |
277,985
-89,796
| -24% | -$550K |
|
|
RICE
628
DELISTED
Rice Energy Inc.
RICE
| $1.72M | 0.01% |
65,672
+46,608
| +244% | +$1.16M |
|
629
Curis
CRIS
$9.53M
| $1.7M | 0.01% |
+326
| New | +$1.19M |
|
630
RTX Corp
RTX
$287B
| $1.7M | 0.01% |
26,552
+8,595
| +48% | +$570K |
|
631
Norwegian Cruise Line
NCLH
$8.89B
| $1.69M | 0.01% |
44,871
-530,121
| -92% | -$20.6M |
|
|
NRF
632
DELISTED
NorthStar Realty Finance Corp.
NRF
| $1.68M | 0.01% |
127,849
-188,287
| -60% | -$2.43M |
|
633
Toro Company
TTC
$8.93B
| $1.67M | 0.01% |
+35,685
| New | +$1.67M |
|
|
LLTC
634
DELISTED
Linear Technology Corp
LLTC
| $1.67M | 0.01% |
+28,165
| New | +$1.58M |
|
635
Yelp
YELP
$1.38B
| $1.66M | 0.01% |
39,858
-1,540,346
| -97% | -$54M |
|
636
PBF Energy
PBF
$7.29B
| $1.65M | 0.01% |
+73,007
| New | +$1.64M |
|
637
Thomson Reuters
TRI
$39.4B
| $1.65M | 0.01% |
+34,364
| New | +$1.66M |
|
638
NXP Semiconductors
NXPI
$68B
| $1.65M | 0.01% |
+16,164
| New | +$1.37M |
|
639
Coca-Cola Femsa
KOF
$21.6B
| $1.64M | 0.01% |
+21,907
| New | +$1.7M |
|
|
MYOK
640
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.63M | 0.01% |
+100,000
| New | +$1.81M |
|
641
American Airlines Group
AAL
$9.58B
| $1.62M | 0.01% |
+44,243
| New | +$1.56M |
|
|
VG
642
DELISTED
Vonage Holdings Corporation
VG
| $1.62M | 0.01% |
245,051
+55,337
| +29% | +$333K |
|
643
Edwards Lifesciences
EW
$47.6B
| $1.61M | 0.01% |
39,975
-20,310
| -34% | -$765K |
|
644
ManpowerGroup
MAN
$2.39B
| $1.6M | 0.01% |
+22,196
| New | +$1.53M |
|
645
Southern Copper
SCCO
$141B
| $1.6M | 0.01% |
65,580
-5,768
| -8% | -$139K |
|
646
Helix Energy Solutions
HLX
$1.46B
| $1.59M | 0.01% |
195,809
+171,541
| +707% | +$1.3M |
|
|
UNVR
647
DELISTED
Univar Solutions Inc.
UNVR
| $1.59M | 0.01% |
+72,568
| New | +$1.42M |
|
|
ZNGA
648
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $1.57M | 0.01% |
540,655
-566,851
| -51% | -$1.58M |
|
|
ODP
649
DELISTED
ODP
ODP
| $1.57M | 0.01% |
43,960
-309,022
| -88% | -$11M |
|
650
8x8 Inc
EGHT
$247M
| $1.57M | 0.01% |
+101,586
| New | +$1.44M |
|
Similar funds
Marshall Wace's Q3 2016 Portfolio in Review
As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.
- Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
- Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
- Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
- Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
- Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.
Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.